跳到正文
Cancer Cell· Serena Porcari, Laura A. Bolte, Johannes R. Björk, Arielle Elkrief, Lisa Derosa, Margherita Ferrari, Angelo Maria Pezzullo, Andrea Severino, William Fusco, Meriem Messaoudene, Carolina Alves Costa Silva, Marine Fidelle, Bertrand Routy, Laura Mählmann, Andrew M. Thomas, Chiara Ciccarese, Camilla Nero, Anna Fagotti, Giampaolo Tortora, Antonio Gasbarrini, Roberto Iacovelli, Emilio Bria, Andy Futreal, Jennifer McQuade, Guido Kroemer, Geke A.P. Hospers, Jacco J. de Haan, Jennifer Wargo, Nicola Segata, Rinse K. Weersma, Gianluca Ianiro, Laurence Zitvogel, Seerave Global Oncobiome Network·· 23 天前精选AI 评分60

抗生素与癌症免疫治疗结局:116个队列、近9.8万例患者的更新荟萃分析

Antibiotics and outcomes of cancer immunotherapy: An updated meta-analysis and clinical applications

AI 导读

一项发表于 Cancer Cell 的更新荟萃分析汇总116个队列、近9.8万例接受免疫检查点抑制剂(ICI)治疗的患者,发现抗生素暴露与更差的总生存期和无进展生存期显著相关。作者同时提出抗菌药物管理和基于微生物组的策略,用于预防和修复抗生素导致的菌群失调。

原文摘要

出版方登记 · OpenAlex

The gut microbiome is a modifiable determinant of response to immune checkpoint inhibitors (ICI), positioning antibiotic exposure as a critical yet under-recognized risk factor for worse survival outcomes in immuno-oncology. As nearly 30% of ICI-treated patients receive antibiotics and indications of cancer immunotherapy are expanding, this issue represents a global challenge in oncology. Here, we paint an updated and comprehensive landscape of antibiotic exposure in immuno-oncology, provide actionable clinical recommendations, and envision future avenues for improvement. First, we describe the biological mechanisms by which antibiotic-induced dysbiosis contributes to ICI resistance. Next, through an updated meta-analysis of 116 cohorts and 97,850 cancer patients treated with ICI, we found a significant association between antibiotic exposure and survival outcomes (overall survival, hazard ratio [HR]: 1.49, 95% confidence interval [CI]: 1.34-1.65; progression-free survival, HR: 1.44, 95% CI: 1.31-1.58). Finally, we discuss antibiotics stewardship and microbiome-centered strategies to prevent, diagnose, and/or repair dysbiosis.

页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文

推荐理由

这项纳入116个队列、近9.8万例患者的更新荟萃分析量化了抗生素暴露与ICI生存结局的关联,可供临床权衡抗生素使用。

来源:Cancer Cell · cell.com